Immunohistochemical analysis revealed increased PSMA expression in primary and metastatic lesions of prostate cancer compared with normal prostate, and PSMA expression was reported to correlate with Gleason score and cancer aggressiveness [13, 14] [26]. The gene discussed is FOLH1; the disease is cancer.